News on Antares from BioPortfolio.com http://www.BioPortfolio.com Consolidated Antares news from BioPortfolio.com Wed, 10 Feb 2010 14:13:52 GMT en Antares Pharma, Inc. - Financial And Strategic Analysis Review - New Report Publishedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034416&HITNO=0&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034416&THISHREF=http://c.moreover.com/click/here.pl%3fz2535781097%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034416&HITNO=0&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034416&THISHREF=http://c.moreover.com/click/here.pl%3fz2535781097%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comOfficialWire: New Report Now Available: Antares Pharma, Inc. - SWOT Analysishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024795&HITNO=1&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024795&THISHREF=http://c.moreover.com/click/here.pl%3fz2529183512%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4024795&HITNO=1&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4024795&THISHREF=http://c.moreover.com/click/here.pl%3fz2529183512%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: ANTARES PHARMA Partner, Teva USA, Introduces New Resources to Support Use of ANTARES' Patient-Friendly Injectohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4007466&HITNO=2&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4007466&THISHREF=http://c.moreover.com/click/here.pl%3fz2521144646%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4007466&HITNO=2&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4007466&THISHREF=http://c.moreover.com/click/here.pl%3fz2521144646%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Skymark Research Initiates Independent Research Coverage on Antares Pharma, Inc.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4006018&HITNO=3&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4006018&THISHREF=http://c.moreover.com/click/here.pl%3fz2520566716%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4006018&HITNO=3&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4006018&THISHREF=http://c.moreover.com/click/here.pl%3fz2520566716%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Skymark Research Initiates Independent Research Coverage on Antares Pharma, Inc.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005365&HITNO=4&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005365&THISHREF=http://c.moreover.com/click/here.pl%3fz2520342251%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4005365&HITNO=4&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4005365&THISHREF=http://c.moreover.com/click/here.pl%3fz2520342251%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: Antares Pharma Inc-Therapeutic Competitors - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4008283&HITNO=5&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4008283&THISHREF=http://c.moreover.com/click/here.pl%3fz2521486872%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4008283&HITNO=5&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4008283&THISHREF=http://c.moreover.com/click/here.pl%3fz2521486872%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Antares Pharma Inc.-Deals & Alliances Report - new market report releasedhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4003394&HITNO=6&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4003394&THISHREF=http://c.moreover.com/click/here.pl%3fz2519457953%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4003394&HITNO=6&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4003394&THISHREF=http://c.moreover.com/click/here.pl%3fz2519457953%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Skymark Research Initiates Independent Research Coverage on Antares Pharma, Inc.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4007332&HITNO=7&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4007332&THISHREF=http://c.moreover.com/click/here.pl%3fz2521079196%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4007332&HITNO=7&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4007332&THISHREF=http://c.moreover.com/click/here.pl%3fz2521079196%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: ANTARES PHARMA Partner, Teva USA, Introduces New Resources to Support Use of ANTARES Patient-Friendly Injectorhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4001499&HITNO=8&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4001499&THISHREF=http://c.moreover.com/click/here.pl%3fz2518456787%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4001499&HITNO=8&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4001499&THISHREF=http://c.moreover.com/click/here.pl%3fz2518456787%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: ANTARES PHARMA Partner, Teva USA, Introduces New Resources to Support Use of ANTARES Patient-Friendly Injector for Growth Hormone Deficiency in Childrenhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999651&HITNO=9&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999651&THISHREF=http://c.moreover.com/click/here.pl%3fz2517572588%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999651&HITNO=9&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999651&THISHREF=http://c.moreover.com/click/here.pl%3fz2517572588%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: ANTARES PHARMA Partner, Teva USA, Introduces New Resources to Support Use of ANTARES Patient-Friendly Injechttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999559&HITNO=10&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999559&THISHREF=http://c.moreover.com/click/here.pl%3fz2517498917%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999559&HITNO=10&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999559&THISHREF=http://c.moreover.com/click/here.pl%3fz2517498917%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: ANTARES PHARMA Partner, Teva USA, Introduces New Resources to Support Use of ANTARES Patient-Friendly Injectorhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999177&HITNO=11&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999177&THISHREF=http://c.moreover.com/click/here.pl%3fz2517347001%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999177&HITNO=11&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999177&THISHREF=http://c.moreover.com/click/here.pl%3fz2517347001%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFort Mills Times: ANTARES PHARMA Partner, Teva USA, Introduces New Resources to Support Use of ANTARES Patient-Friendly Injector for Growth Hormone Deficiency in Childrenhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000752&HITNO=12&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000752&THISHREF=http://c.moreover.com/click/here.pl%3fz2518166274%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000752&HITNO=12&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000752&THISHREF=http://c.moreover.com/click/here.pl%3fz2518166274%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: ANTARES PHARMA Partner, Teva USA, Introduces New Resources to Support Use of ANTARES' Patient-Friendly Injector for Growth Hormone Deficiency in Childrenhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000046&HITNO=13&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000046&THISHREF=http://c.moreover.com/click/here.pl%3fz2517806354%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4000046&HITNO=13&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4000046&THISHREF=http://c.moreover.com/click/here.pl%3fz2517806354%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comI Stock Analyst: ANTARES PHARMA Partner, Teva USA, Introduces New Resources to Support Use of ANTARES' Patient-Friendly Injector for Growth Hormone Deficiency in Childrenhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999265&HITNO=14&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999265&THISHREF=http://c.moreover.com/click/here.pl%3fz2517400572%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3999265&HITNO=14&MSIZE=80&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Antares&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3999265&THISHREF=http://c.moreover.com/click/here.pl%3fz2517400572%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Wire via Yahoo!: